Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases
HSA variation in rates of curative-intent therapy for CRCLM was associated with population-level changes in survival. These data quantify the expected improvements associated with efforts to increase patient access to curative-intent therapies for CRCLM.
Authors
- Russell C. Langan
- Elisa V. Bandera (ORCID: https://orcid.org/0000-0002-8789-2755)
- Alexander A. Parikh (ORCID: https://orcid.org/0000-0002-2730-2354)
- Vasileios Tsagkalidis (ORCID: https://orcid.org/0000-0002-6870-3082)
- Mariam F. Eskander (ORCID: https://orcid.org/0000-0001-8857-3564)
- Haejin In
- Elizabeth A. Handorf (ORCID: https://orcid.org/0000-0003-0445-8978)
- Timothy J. Kennedy
- Miral S. Grandhi
- Brett L. Ecker (ORCID: https://orcid.org/0000-0003-2536-9261)
- David G. Brauer (ORCID: https://orcid.org/0000-0002-0251-4350)
- Patrick M. Boland (ORCID: https://orcid.org/0000-0002-4213-8847)
- Benjamin Bates (ORCID: https://orcid.org/0000-0002-1221-4028)
- J. Carlos Maggi
- Hari S. Iyer (ORCID: https://orcid.org/0000-0002-7596-9049)
- Charu Verma
- Henry A. Pitt (ORCID: https://orcid.org/0000-0003-4608-9867)
Institutions
- Rutgers, The State University of New Jersey (US)
- Saint Barnabas Medical Center (US)
- University of Minnesota (US)
- The University of Texas MD Anderson Cancer Center (US)
- The University of Texas at San Antonio Health Science Center (US)
- Johnson University (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1245/s10434-025-17486-4
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64